U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5508155081Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single TabletsCompletedHas ResultsHealthyDrug: 2x500 mg Metformin (Glumetza)|Drug: 5 mg Linagliptin/1000 mg Metformin FDC|Drug: 5 mg Linagliptin (Tradjenta)|Drug: 5 mg Linagliptin (Tradjenta)|Drug: 3x500 mg Metformin (Glumetza)|Drug: 5 mg Linagliptin (Tradjenta)|Drug: 2 x 500 mg Metformin (Glumetza)|Drug: 5 mg Linagliptin/1000mg Metformin FDC|Drug: 2 x 2.5 mg Linagliptin/750 mg Metformin FDChttps://ClinicalTrials.gov/show/NCT01845077
5508255082A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes PatientsCompletedNo Results AvailableDiabetes Type 2Drug: DM199|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01845064
5508355083Is There a Comorbidity Between Migraine and Allergic Rhinitis?CompletedNo Results AvailableMigraine|Allergic Rhinitishttps://ClinicalTrials.gov/show/NCT01845051
5508455084Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle GlaucomaCompletedNo Results AvailableGlaucomaDrug: OTX-TPa ~4µg/day over 2 mos. with natural tears drops|Drug: OTX-TPb ~3µg/day over 3 months with natural tears drops|Drug: Timolol Maleate (0.5%) dosed twice daily with punctum plug without drughttps://ClinicalTrials.gov/show/NCT01845038
5508555085Study of Safety of Foradil in Patients With Persistent AsthmaRecruitingNo Results AvailablePersistent AsthmaDrug: Formoterol|Drug: Fluticasone propionate 100 mcg|Drug: Fluticasone propionate 250 mcg|Drug: Fluticasone propionate 500 mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01845025
5508655086Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional HemodialysisTerminatedNo Results AvailableEnd Stage Renal DiseaseOther: Daily hemodialysis at low dialysate flowhttps://ClinicalTrials.gov/show/NCT01845012
5508755087Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksRecruitingNo Results AvailableProstate CancerBehavioral: Personal Patient Profile - Prostate (P3P)|Behavioral: Standard prostate cancer information websiteshttps://ClinicalTrials.gov/show/NCT01844999
5508855088Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.RecruitingNo Results AvailableNewly Diagnosed|Advanced Ovarian Cancer|FIGO Stage III-IV|BRCA Mutation|Complete Response|Partial Response|First Line Platinum ChemotherapyDrug: Olaparib 300mg tabletshttps://ClinicalTrials.gov/show/NCT01844986
5508955089Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis PatientsCompletedNo Results AvailablePsoriasisDrug: M518101|Drug: Vehiclehttps://ClinicalTrials.gov/show/NCT01844973
5509055090Laparoscopic Single Incision -Vs- Multiple Incision Gastric Band SurgeryCompletedNo Results AvailableSurgery|Post-operative Pain|Post-operative RecoveryProcedure: Single Incision Gastric Band Insertion|Procedure: Multiple Incision Gastric Band Insertionhttps://ClinicalTrials.gov/show/NCT01844960
5509155091Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractRecruitingNo Results AvailableUrothelial Carcinoma|Bladder Cancer|Renal Pelvis Cancer|Ureter Cancer|Urethra CancerDrug: Vinflunine|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT01844947
5509255092Impact of Prehabilitation in Total Knee ReplacementRecruitingNo Results AvailableTotal Knee ArthroplastyOther: Prehabilitationhttps://ClinicalTrials.gov/show/NCT01844934
5509355093High Resolution Optical Imaging of the Esophagus Using the Nvision Volumetric Laser Endomicroscopy (VLEâ„¢) Imaging SystemCompletedNo Results AvailableUndergoing Esophagogastroduodenoscopy (EGD)https://ClinicalTrials.gov/show/NCT01844921
5509455094Electroacupuncture for Postoperative Ileus After Laparoscopic Rectal Cancer SurgeryRecruitingNo Results AvailablePostoperative IleusProcedure: Electroacupuncturehttps://ClinicalTrials.gov/show/NCT01844908
5509555095Methotrexate-Inadequate Response Autoinjector Device Sub StudyCompletedHas ResultsRheumatoid ArthritisDrug: Abatacepthttps://ClinicalTrials.gov/show/NCT01844895
5509655096The Effects of Dietary Fiber in CKD: A Systematic Review and Meta-analysisCompletedNo Results AvailableChronic Kidney Diseasehttps://ClinicalTrials.gov/show/NCT01844882
5509755097An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine MepesuccinateCompletedNo Results AvailableHematologic Malignancies|Solid TumorsDrug: omacetaxine mepesuccinatehttps://ClinicalTrials.gov/show/NCT01844869
5509855098Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal InfectionsActive, not recruitingNo Results AvailableComplicated Intra-abdominal InfectionsDrug: Eravacycline|Drug: Ertapenemhttps://ClinicalTrials.gov/show/NCT01844856
5509955099Optical Frequency Domain Imaging (OFDI) Assessed Strut Coverage of New Terumo DESActive, not recruitingNo Results AvailableCoronary Artery DiseaseDevice: TCD-10023 drug eluting stenthttps://ClinicalTrials.gov/show/NCT01844843
5510055100Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric PatientsCompletedNo Results AvailableAnesthesiaDrug: Tetracaine HCl 3% and Oxymetazoline HCl 0.05%|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01844830
5510155101Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic CancerDrug: OGX-427|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01844817
5510255102A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)CompletedNo Results AvailableHealthyBiological: PF-06438179|Biological: Remicade|Biological: Remicadehttps://ClinicalTrials.gov/show/NCT01844804
5510355103An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNo Results AvailableNon-small Cell Lung CancerDrug: OCZ103-OS|Drug: Platinum|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT01844791
5510455104Ease of Use and Microbial Contamination of TIP vs Nebulised TIS and Nebulised ColistimethateRecruitingNo Results AvailableCystic FibrosisDrug: Tobramycin Inhalation Powder|Drug: Tobramycin inhalation solution|Drug: Colistimethatehttps://ClinicalTrials.gov/show/NCT01844778
5510555105Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.RecruitingNo Results AvailableLeukemia|Leukemia,Pediatric|Leukemia, Myleiod|Leukemia, Mylegenous, Chronic|Leukemia, Mylegenous, Accelerated|BCR-ABL Positive|Myeloproliferative Disorder|Bone Marrow Disease|Hematologic Diseases|Neoplastic Processes|Imatinib|Dasatinib|Enzyme Inhibitor|PrDrug: nilotinibhttps://ClinicalTrials.gov/show/NCT01844765
5510655106A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With AcneCompletedNo Results AvailableAcne VulgarisDrug: NVN1000 1% Gel|Drug: NVN1000 4% Gel|Drug: Vehicle Gelhttps://ClinicalTrials.gov/show/NCT01844752
5510755107A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 GelCompletedNo Results AvailableAcne VulgarisDrug: NVN1000 4% Gel|Drug: Vehicle Gelhttps://ClinicalTrials.gov/show/NCT01844739
5510855108Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric IllnessRecruitingNo Results AvailableLearning and Memory in Healthy Individuals and Those With Psychiatric IllnessDrug: GLYX-13|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01844726
5510955109Evaluation of Sun Protection Education for Kidney Transplant RecipientsCompletedNo Results AvailableUnspecified Complications of Kidney Transplant|Disorder Related to Renal TransplantationBehavioral: Workbookhttps://ClinicalTrials.gov/show/NCT01844713
55110551101/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight GainNot yet recruitingNo Results AvailableHigh Risk MC4R Genotype|Low Risk MC4R Genotype|One Week or Less Antipsychotic Lifetime ExposureDrug: Ziprasidone|Drug: aripiprazole, quetiapine, or risperidonehttps://ClinicalTrials.gov/show/NCT01844700

* Görseller ve İçerik tekif hakkına sahip olabilir